Change of HAART [14]

Lancet

Volumn 353, Issue 9167, 1999, Pages 1888-

  Edlin, B R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DRUG ACTIVITY; DRUG NOMENCLATURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; RETROVIRUS INFECTION; DRUG COMBINATION; HUMAN; NOMENCLATURE;

ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HUMANS; TERMINOLOGY;

EID: 85044703645     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)75102-3     Document Type: Letter

References (4)

1. B Ledergerber M Egger M Opravil Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study Lancet 353 1999 863 868
2. RW Chun L Stuyver SB Mizell Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy Proc Natl Acad Sci USA 94 1997 13193 13197
3. D Finzi M Hermankova T Pierwson Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy Science 278 1997 1295 1300
4. JG O'Shea “Two minutes with venus, two years with mercury”: mercury as an antisyphilitic chemotherapeutic agent J R Soc Med 83 1990 392 395